241 related articles for article (PubMed ID: 18293689)
1. Pregnancy and inflammatory bowel disease: a prospective case-control study.
Malgarinos G; Gikas A; Delicha E; Stamataki A; Georgopoulos F; Papadimitriou A; Stanciu C; Triantafillidis JK
Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):613-9. PubMed ID: 18293689
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study.
Molnár T; Farkas K; Nagy F; Lakatos PL; Miheller P; Nyári T; Horváth G; Szepes Z; Marik A; Wittmann T
Scand J Gastroenterol; 2010 Nov; 45(11):1302-6. PubMed ID: 20602569
[TBL] [Abstract][Full Text] [Related]
3. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.
Reddy D; Murphy SJ; Kane SV; Present DH; Kornbluth AA
Am J Gastroenterol; 2008 May; 103(5):1203-9. PubMed ID: 18422816
[TBL] [Abstract][Full Text] [Related]
4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.
Rahimi R; Nikfar S; Rezaie A; Abdollahi M
Reprod Toxicol; 2008 Feb; 25(2):271-5. PubMed ID: 18242053
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.
Bortlik M; Machkova N; Duricova D; Malickova K; Hrdlicka L; Lukas M; Kohout P; Shonova O; Lukas M
Scand J Gastroenterol; 2013 Aug; 48(8):951-8. PubMed ID: 23834232
[TBL] [Abstract][Full Text] [Related]
7. Pancreatitis in inflammatory bowel diseases.
Pitchumoni CS; Rubin A; Das K
J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
[TBL] [Abstract][Full Text] [Related]
8. Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy.
Ramos JM; García-Sepulcre MF; Masiá M; Brotons A; Grau MC; Gutiérrez F
Rev Esp Enferm Dig; 2010 Oct; 102(10):614-6. PubMed ID: 21039077
[No Abstract] [Full Text] [Related]
9. [Therapy of chronic inflammatory bowel diseases].
Beglinger C
Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
[TBL] [Abstract][Full Text] [Related]
10. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey.
Mañosa M; Navarro-Llavat M; Marín L; Zabana Y; Cabré E; Domènech E
Scand J Gastroenterol; 2013 Apr; 48(4):427-32. PubMed ID: 23477328
[TBL] [Abstract][Full Text] [Related]
11. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy.
Hutson JR; Matlow JN; Moretti ME; Koren G
J Obstet Gynaecol; 2013 Jan; 33(1):1-8. PubMed ID: 23259868
[TBL] [Abstract][Full Text] [Related]
12. [Pregnancy outcome in inflammatory bowel diseases].
Tennenbaum R; Marteau P; Elefant E; Rambaud JC; Modigliani R; Gendre JP; Cosnes J
Gastroenterol Clin Biol; 1999 May; 23(5):464-9. PubMed ID: 10429848
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
[TBL] [Abstract][Full Text] [Related]
14. [Inflammatory diseases of the digestive system and pregnancy: clinical case and review of the literature].
Restellini A
Schweiz Rundsch Med Prax; 1989 May; 78(19):560-4. PubMed ID: 2662327
[TBL] [Abstract][Full Text] [Related]
15. [Pentasa (mesalazine) and pregnancy].
Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
[TBL] [Abstract][Full Text] [Related]
16. Management of varicella infection during the course of inflammatory bowel disease.
Mouzas IA; Greenstein AJ; Giannadaki E; Balasubramanian S; Manousos ON; Sachar DB
Am J Gastroenterol; 1997 Sep; 92(9):1534-7. PubMed ID: 9317080
[TBL] [Abstract][Full Text] [Related]
17. [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
Gisbert JP; Gomollón F; Maté J; Pajares JM
Gastroenterol Hepatol; 2002; 25(6):401-15. PubMed ID: 12069704
[No Abstract] [Full Text] [Related]
18. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.
Dominitz JA; Young JC; Boyko EJ
Am J Gastroenterol; 2002 Mar; 97(3):641-8. PubMed ID: 11926208
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study.
Bortoli A; Saibeni S; Tatarella M; Prada A; Beretta L; Rivolta R; Politi P; Ravelli P; Imperiali G; Colombo E; Pera A; Daperno M; Carnovali M; de Franchis R; Vecchi M;
J Gastroenterol Hepatol; 2007 Apr; 22(4):542-9. PubMed ID: 17376049
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Daperno M; Sostegni R; Canaparo R; Serpe L; Lavagna A; Crocellà L; Castagno F; Vernetto A; Rigazio C; Ercole E; D'Antico S; Pera A; Zara G; Rocca R
Aliment Pharmacol Ther; 2009 Oct; 30(8):843-53. PubMed ID: 19650826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
